Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Briacell Therapeutics Corp (BCTXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 18,258
  • Shares Outstanding, K 158,900
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0820 +40.12%
on 09/05/18
0.1158 -0.78%
on 09/21/18
+0.0093 (+8.81%)
since 08/21/18
3-Month
0.0820 +40.12%
on 09/05/18
0.1300 -11.62%
on 06/25/18
-0.0131 (-10.23%)
since 06/21/18
52-Week
0.0680 +68.97%
on 05/18/18
0.1387 -17.16%
on 12/13/17
-0.0237 (-17.10%)
since 09/18/17

Most Recent Stories

More News
Coverage Initiated for BriaCell Therapeutics Corp. via NetworkNewsWire

via NetworkWire - BriaCell Therapeutics Corp. (OTCQB: BCTXF; TSX: BCT.V) (BriaCell or the Company), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology,...

BCTXF : 0.1149 (+14.90%)
Dr. William Williams, BriaCell's President & CEO, is Featured in an Exclusive New Audio Interview at SmallCapVoice.com

SmallCapVoice.com, Inc. and BriaCell Therapeutics Corp. ("BriaCell") (BCT.V) (BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced today...

BCTXF : 0.1149 (+14.90%)
BriaCell Adds New Clinical Site To Phase IIa Study in Advanced Breast Cancer and Expands R&D Team

-- The addition of the Cancer Center of Kansas (CCK) as a new clinical trial site is expected to accelerate patient enrollment in both clinical trials.

BCTXF : 0.1149 (+14.90%)
BCT.VN : 0.140 (unch)
BriaCell to Hold Conference Call on Key Clinical Findings; Activities

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to provide a Corporate...

BCTXF : 0.1149 (+14.90%)
BCT.VN : 0.140 (unch)
BriaCell Therapeutics Corp. to Present at The MicroCap Conference on June 21st in Toronto at the Sheraton Centre Hotel

TORONTO, ON / ACCESSWIRE / June 13, 2018 / BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy...

BCTXF : 0.1149 (+14.90%)
BCT.VN : 0.140 (unch)
BriaCell Activates A Clinical Site in Florida for Phase IIa Study of its Lead Candidate in Advanced Breast Cancer

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce that Sylvester...

BCTXF : 0.1149 (+14.90%)
BCT.VN : 0.140 (unch)
BriaCell Provides Highlights of Scientific and Clinical Findings at AACR

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce that it...

BCTXF : 0.1149 (+14.90%)
BCT.VN : 0.140 (unch)
Dr. Williams, BriaCell Therapeutics Corp.'s President & CEO, is Featured in an Exclusive New Audio Interview with SmallCapVoice.com

SmallCapVoice.com, Inc. and BriaCell Therapeutics Corp. ("BriaCell") (TSXV:BCT.V) (OTC:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced...

BCTXF : 0.1149 (+14.90%)
BriaCell to Present Encouraging Clinical Data at AACR 2018

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced today that it has been...

BCTXF : 0.1149 (+14.90%)
BCT.VN : 0.140 (unch)
BriaCell's Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce the acceptance...

BCTXF : 0.1149 (+14.90%)
BCT.VN : 0.140 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BCTXF with:

Key Turning Points

2nd Resistance Point 0.1174
1st Resistance Point 0.1161
Last Price 0.1149
1st Support Level 0.1133
2nd Support Level 0.1118

See More

52-Week High 0.1387
Last Price 0.1149
Fibonacci 61.8% 0.1117
Fibonacci 50% 0.1033
Fibonacci 38.2% 0.0950
52-Week Low 0.0680

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar